DE2058892A1 - Chemisches Verfahren - Google Patents

Chemisches Verfahren

Info

Publication number
DE2058892A1
DE2058892A1 DE19702058892 DE2058892A DE2058892A1 DE 2058892 A1 DE2058892 A1 DE 2058892A1 DE 19702058892 DE19702058892 DE 19702058892 DE 2058892 A DE2058892 A DE 2058892A DE 2058892 A1 DE2058892 A1 DE 2058892A1
Authority
DE
Germany
Prior art keywords
group
agent
complex
acylating
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702058892
Other languages
German (de)
English (en)
Inventor
Leonard Mervyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE2058892A1 publication Critical patent/DE2058892A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19702058892 1969-12-01 1970-11-30 Chemisches Verfahren Pending DE2058892A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5863169 1969-12-01

Publications (1)

Publication Number Publication Date
DE2058892A1 true DE2058892A1 (de) 1971-06-09

Family

ID=10482055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702058892 Pending DE2058892A1 (de) 1969-12-01 1970-11-30 Chemisches Verfahren

Country Status (8)

Country Link
US (1) US3798211A (OSRAM)
JP (1) JPS4917280B1 (OSRAM)
BE (1) BE759614A (OSRAM)
CH (1) CH575961A5 (OSRAM)
DE (1) DE2058892A1 (OSRAM)
FR (1) FR2072656A5 (OSRAM)
GB (1) GB1315969A (OSRAM)
NL (1) NL7017357A (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102391340A (zh) * 2011-10-31 2012-03-28 河北玉星生物工程有限公司 一种甲钴胺的制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133951A (en) * 1975-05-08 1979-01-09 The Radiochemical Centre Limited Vitamin B-12 cobalt-57 and process
DE2908670A1 (de) * 1979-03-06 1980-09-18 Biotechnolog Forschung Gmbh Verfahren zur herstellung von metallcorrinoiden
DE60026354T2 (de) * 1999-12-09 2006-11-09 Eisai Co., Ltd. Verfahren zur herstellung von methylcobalamin
EP1394174B1 (en) 2001-06-05 2015-11-11 Eisai R&D Management Co., Ltd. Process for producing methylcobalamin
ES2264374B1 (es) * 2005-03-23 2007-11-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de la metilcobalamina.
CN101948494B (zh) * 2010-09-14 2012-11-21 河北华荣制药有限公司 一种腺苷钴胺提取方法
WO2012165934A1 (es) * 2011-05-30 2012-12-06 Interquim, S.A. De C.V. Proceso de síntesis de metilcobalamina
CN102321137B (zh) * 2011-07-25 2014-04-23 河北玉星生物工程有限公司 一种腺苷钴胺的制备方法
CN105218608A (zh) * 2015-10-29 2016-01-06 无锡福祈制药有限公司 一种甲钴胺的制备方法
JP6867409B2 (ja) * 2016-07-08 2021-04-28 ヘルステック バイオ アクティブズ,エス.エル.ユー メチルコバラミンの精製方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102391340A (zh) * 2011-10-31 2012-03-28 河北玉星生物工程有限公司 一种甲钴胺的制备方法

Also Published As

Publication number Publication date
CH575961A5 (OSRAM) 1976-05-31
JPS4917280B1 (OSRAM) 1974-04-27
BE759614A (fr) 1971-06-01
US3798211A (en) 1974-03-19
FR2072656A5 (OSRAM) 1971-09-24
NL7017357A (OSRAM) 1971-06-03
GB1315969A (en) 1973-05-09

Similar Documents

Publication Publication Date Title
DE2508312C2 (OSRAM)
EP0003229B1 (de) Neues Verfahren zur Herstellung von Nucleosiden
DE2058892A1 (de) Chemisches Verfahren
DE69022176T2 (de) Zwischenverbindung für 2-alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2-alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.
DE60014028T2 (de) Funktionalisierte verbindung, gegebenenfalls markierte polynukleotide und verfahren zur detektion einer zielnukleinsäure
DE1695303A1 (de) Verfahren zur Herstellung von Nucleosid-5'-diphosphaten und -triphosphaten sowie Mono- und Oligonucleotidylnuclesid-5'-diphosphaten und triphosphaten
DE60121425T2 (de) Verfahren zur Herstellung von 2-Chlor-9-(2-deoxy-2-flour-ß-D-arabinofuranosyl)-9H-purin-6-amin
DE69421224T2 (de) Nukleosidderivate und Verfahren zu deren Herstellung
CH515249A (de) Verfahren zur Herstellung von 2',5'- und 3',5'- Dinucleosidphosphaten
DE2310329A1 (de) Arabinofuranosylcytosine und verfahren zu ihrer herstellung
DE2721466A1 (de) Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
CH467277A (de) Verfahren zur Herstellung von Cobalticorrinoiden
DE2756057C2 (OSRAM)
DE1240863B (de) Verfahren zur Oxydation von Alkoholen zu den entsprechenden Aldehyden oder Ketonen
DE1670016C3 (de) Verfahren zur Herstellung von 5'-Ribunucleotiden durch selektive Phosphorylierung
DE2308801A1 (de) Verfahren zur herstellung von nucleosid-5'-diphosphat-aethanolaminen
DE1620534A1 (de) Verfahren zur Herstellung von Purinnucleosiden
Walker et al. Preparation and properties of some cytosine derivatives
DE1645979C3 (de) Verfahren zur Herstellung von Ribonucleosid-5'-monophosphatea
DE3712818C2 (OSRAM)
DE2149740C3 (de) Verfahren zur Herstellung von gegebenenfalls substituierten Co-Alkyl-Cobamiden
El Khadem et al. Two crystalline pentofuranosyl bromides: tri-O-(p-nitrobenzoyl)-β-D-ribofuranosyl bromide and tri-O-(p-nitrobenzoyl)-α, β-D-xylofuranosyl bromide
DE19618727C2 (de) Herstellung alkylierter Nucleosid-3'-Phosphate
DE1645984B2 (de) Verfahren zur Herstellung von 51-Ribofuranosyl-, 5"-Arabinofuranosyl- und o'-Glucopyranosyl-Nucleotiden
CH512482A (de) Verfahren zur Herstellung von Cobalticorrinoiden